Innovation and Equity in an Age of Gene Editing
By Charis Thompson, Ruha Benjamin, Jessica Cussins and Marcy Darnovsky,
The Guardian
| 05. 19. 2015
The first day of BEINGS2015, “A Gathering of Global Thought Leaders to Reach Consensus on the Direction of Biotechnology for the 21st Century”, in Atlanta, coincided with the announcement by the National Academy of Science and National Academy of Medicine of an initiative to look into “promising new treatments for disease,” given that “recent experiments to attempt to edit human genes also have raised important questions about the potential risks and ethical concerns of altering the human germline.”
It is the time of prizes and tussles over intellectual property and experiments on non-viable human embryos, and, calls for caution from CRISPR-CAS9 scientists (here and here and here). Also still in the air is the UK’s political vote, despite an EU consensus against germline genetic modification (was this the first step of ‘Brexit’?) to allow clinics to apply for permission to undertake IVF with mitochondrial DNA donation, a form of germ cell genetic modification that requires egg donation. These technologies are widely considered threshold technologies with unknown and irreversible consequences for individuals, humanity and the environment.
During...
Related Articles
The Center for Genetics and Society is delighted to recommend the current edition of GMWatch Review – Number 589. UK-based GMWatch, a long-standing ally, was founded in 1998 by Jonathan Matthews as an independent organization seeking to counter the enormous corporate political power and propaganda of the GMO industry and its supporters. Matthews and Claire Robinson are its directors and managing editors.
CGS works to ensure that social justice, equity, human rights, and democratic governance are front...
By Harry Hunter, PET BioNews | 08.11.2025
The Parliamentary Office of Science and Technology has announced plans to publish a POSTnote and called for submissions on surrogacy law in the UK and internationally.
The current UK surrogacy laws, largely based on legislation from the 1980s, have been...
By Cade Metz, The New York Times | 08.04.2025
Image by Mike MacKenzie / CC BY 2.0
In downtown Berkeley, an old hotel has become a temple to the pursuit of artificial intelligence and the future of humanity. Its name is Lighthaven.
Covering much of a city block, this...
By Keith Casebonne and Jodi Beckstine [with CGS' Katie Hasson], Disability Deep Dive | 07.24.2025
In this episode of Disability Deep Dive, hosts Keith and Jodi explore the complex interplay between disability science, technology, and ethics with guest Katie Hasson, Associate Director at the Center for Genetics and Society. The conversation delves into...
